Recombinant SARS-CoV-2 Vaccine (Patronus Biotech)

N/A

Report date: 2023/07/05 20:01:32

Base Information

Drug NameRecombinant SARS-CoV-2 Vaccine (Patronus Biotech)
Drug Alias NameRecombinant SARS-CoV-2 trivalent vaccine (CHO Cell) (Patronus Biotech)LYB002V14LYB002V14ALYB002CALYB002
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Recombinant vector vaccineVaccines > Vaccine type > Multivalent vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesYantai Patronus Biotech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGuangzhou Patronus Biotech Co LtdYantai Patronus Biotech Co Ltd
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A